人充满活力 发表于 2025-3-26 22:44:12
http://reply.papertrans.cn/67/6649/664870/664870_31.pngWorking-Memory 发表于 2025-3-27 04:41:26
,An Introduction to „Recent Trends in the Biotechnology Industry: Development and Manufacturing of Rng drugs predicted to be biologics. From 1986 to 2014 several first-in-class, advance-in-class, and breakthrough designated therapeutic options were approved, with advanced therapies such as immuno-oncology and cell-based therapies being approved for several indications.腐败 发表于 2025-3-27 09:02:42
http://reply.papertrans.cn/67/6649/664870/664870_33.png谆谆教诲 发表于 2025-3-27 13:22:34
http://reply.papertrans.cn/67/6649/664870/664870_34.png墙壁 发表于 2025-3-27 15:25:25
http://reply.papertrans.cn/67/6649/664870/664870_35.png蒙太奇 发表于 2025-3-27 20:18:37
Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perstools for iPSC generation, and single-use controlled-environment systems for autologous cell production. These platforms address the challenges of manufacturing cell products in greater numbers while maintaining process robustness and product quality.虚情假意 发表于 2025-3-28 01:20:37
http://reply.papertrans.cn/67/6649/664870/664870_37.pngburnish 发表于 2025-3-28 02:39:06
Book 2018for their synthesis and purification..In general, special volumes are edited by well-known guest editors. The series editor and publisher will however always be pleased to receive suggestions and supplementary information. Manuscripts are accepted in English.Awning 发表于 2025-3-28 08:04:51
Manufacturing of Proteins and Antibodies: Chapter Downstream Processing Technologies,s. In this chapter we describe centrifugation and depth filtration harvesting methods, share strategies for harvest optimization, present recent developments in centrifugation scale-down models, and review alternative harvesting technologies.表示问 发表于 2025-3-28 13:02:00
http://reply.papertrans.cn/67/6649/664870/664870_40.png